|
Volumn 20, Issue 1, 2002, Pages 113-115
|
Phase II trial of amonafide in central nervous system tumors: A Southwest Oncology Group Study
a b c d e f d d |
Author keywords
Amonafide; Central nervous system tumors
|
Indexed keywords
AMONAFIDE;
ADULT;
ANEMIA;
ARTICLE;
ASTROCYTOMA;
CENTRAL NERVOUS SYSTEM TUMOR;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GLIOMA;
GRANULOCYTOPENIA;
HEADACHE;
HEMATOLOGIC DISEASE;
HUMAN;
LEUKOPENIA;
MALE;
NAUSEA AND VOMITING;
NEUROLOGIC DISEASE;
OLIGODENDROGLIOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TUMOR RECURRENCE;
ADULT;
ANTINEOPLASTIC AGENTS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMIDES;
INFUSIONS, INTRAVENOUS;
ISOQUINOLINES;
MALE;
NAPHTHALIMIDES;
|
EID: 0036204930
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1014488922368 Document Type: Article |
Times cited : (6)
|
References (10)
|